Yahoo Web Search

Search results

1. • 

     AI enabled body composition analysis predicts outcomes for patients with lung cancer treated with...

     Medical Xpress· 6 days ago

     Chaunzwa and senior author Hugo Aerts, Ph.D., director of the AIM Program, and associate professor...

2. • 

     Reproductive cancer survivor beats disease, but is left with medical debt crisis

     Gannett via AOL· 7 days ago

     But students who seek preventative care services and prescription drugs out of network must...

3. • 

     Providing hope, LewisGale becomes first in Virginia to offer newtreatment for colon cancer patients

     WSLS Newschannel 10 Roanoke· 5 days ago

     A first-of-its-kind treatment in Virginia is providing hope to people with advanced stages of colon...

4. • 

     All over the body: Here are the key clinical trials from Bay Area firms - San Francisco Business...

     The Business Journals· 5 days ago

     Since the turn of the millennium, Bay Area organizations and researchers have launched more than 300...

5. • 

     What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?

     Benzinga via Yahoo Finance· 6 days ago

     Thursday, Verastem Oncology (NASDAQ:VSTM) announced the initial interim safety and efficacy results...

6. • 

     AstraZeneca and Daiichi Sankyo’s ADC improves survival in NSCLC trial

     Clinical Trials Arena via Yahoo Finance· 3 days ago

     “These results reinforce the potential for datopotamab deruxtecan to replace conventional ...

7. • Antibody–peptide inhibitor conjugates: A new path for cancer therapy

     Medical Xpress· 14 hours ago

     An example of essential proteins hijacked by cancer cells are the cathepsins, a family of enzymes that is responsible for breaking down other proteins and remodeling the body's tissues. Cathepsins ...

8. • Annual General Meeting in Cantargia AB

     Digital Journal· 6 days ago

     About CantargiaCantargia AB (publ), reg. no. 556791-6019, is a biotechnology company that develops antibody-based treatments for life-threatening diseases and has established ...

9. • Delcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath's Board of Directors -...

     Benzinga· 2 days ago

     Delcath Systems, Inc. DCTH (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, is pleased ...

10. • AbbVie Showcases Robust Solid Tumor Pipeline at ASCO 2024 with New Data from Its Innovative...

      The Longview News-Journal· 2 days ago

      New safety and efficacy data in heavily pre-treated patients with metastatic colorectal cancer (CRC), from a Phase 1 study of ABBV-400, a next-generation, potential best-in-class c-Met directed ...